Avricore Health Inc. (TSXV:AVCR)

Market Cap	5.57M
Revenue (ttm)	4.10M
Net Income (ttm)	-914.88K
Shares Out	101.29M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,300
Average Volume	47,195
Open	0.0550
Previous Close	0.0600
Day's Range	0.0550 - 0.0550
52-Week Range	0.0350 - 0.3350
Beta	-1.63
RSI	49.96
Earnings Date	May 29, 2025

About Avricore Health

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1996
• Employees: 26
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: AVCR

Financial Performance

In 2024, Avricore Health's revenue was 4.79 million, an increase of 37.32% compared to the previous year's 3.49 million. Losses were -668,977, -4.60% less than in 2023.